0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Paediatric medicine

Buy Now

Safety Efforts in Pediatric Drug Development (Hardcover, New) Loot Price: R2,070
Discovery Miles 20 700
You Save: R194 (9%)
Safety Efforts in Pediatric Drug Development (Hardcover, New): Conor D. Byrne

Safety Efforts in Pediatric Drug Development (Hardcover, New)

Conor D. Byrne

 (sign in to rate)
List price R2,264 Loot Price R2,070 Discovery Miles 20 700 | Repayment Terms: R189 pm x 12* You Save R194 (9%)

Bookmark and Share

Expected to ship within 12 - 17 working days

This book focuses on the safety efforts being implemented in paediatric drug development. Although children suffer from many of the same diseases as adults and are often treated with the same drugs, only about one-third of the drugs that are prescribed for children have been studied and labelled for paediatric use. This has placed children taking drugs for which there have not been adequate paediatric drug studies at risk of being exposed to ineffective treatment or receiving incorrect dosing. In order to encourage the study of more drugs for paediatric use, Congress passed the Best Pharmaceuticals for Children Act (BPCA) in 2002 to provide marketing incentives to drug manufacturers for conducting paediatric drug studies. Drug manufacturers may obtain six months of additional market exclusivity for drugs on which they have conducted paediatric studies in accordance with pertinent law and regulations. This book also evaluates the impact of BPCA on labelling drugs for paediatric use and the process by which the labelling was changed, and illustrates the range of diseases treated by the drugs studied under BPCA. Additionally this book provides guidance on the role and timing of animal studies in the non-clinical safety evaluation of therapeutics intended for the treatment of paediatric patients. The guidance discusses some conditions under which juvenile animals can be meaningful predictors of toxicity in paediatric patients and makes recommendations on non-clinical testing. This book consists of public documents which have been located, gathered, combined, reformatted, and enhanced with a subject index, selectively edited and bound to provide easy access.

General

Imprint: nova science publishers
Country of origin: United States
Release date: May 2010
First published: December 2009
Editors: Conor D. Byrne
Dimensions: 155 x 230 x 14mm (L x W x T)
Format: Hardcover
Pages: 133
Edition: New
ISBN-13: 978-1-60741-565-7
Categories: Books > Medicine > Clinical & internal medicine > Paediatric medicine > General
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 1-60741-565-8
Barcode: 9781607415657

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners